ReviewDrugs2024

Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies.

Bennett A Caughey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.